Clinical trial GO29674
A Phase Ib, Open-Label, Dose-escalation Study of the safety and Pharmacokinetics of MOXR0916 and MPDL3280A in Patients with Locally Advanced or Metastatic Solid Tumors
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Genentech-Roche |
| EudraCT Identifier | 2015-000516-18 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02410512 |
| Inclusion criteria | any line |
| Last update |